*Benzonase® Nuclease is manufactured by Merck KGaA, Darmstadt, Germany and is covered by US Patent 5,173,418 and EP Patent 0,229,866. Nycomed Pharma A/S (Denmark) claims worldwide patent rights to Benzonase® Nuclease, which are licensed exclusively to Merck KGaA, Darmstadt, Germany. Benzonase® Nuclease is a registered trademark of Merck KGaA, Darmstadt, Germany. Warning: The virus purified using this kit is capable of infecting human or animal cells and could, depending on the gene insert, expose the user to potentially hazardous biological material. Adenoviruses have been designated as Level 2 biological agents. All protocols detailed in these operating instructions must be performed under at least Biosafety Level 2 working condition this kit is NOT intended for human or animal diagnostic or therapeutic applications. |